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Introduction
A solid phase extraction (SPE) method for extraction and clean up of nine 
synthetic corticosteroids from porcine and bovine urine has been optimised 
for quantification by reversed-phase high-performance liquid chromatography 
negative electrospray ionisation mass spectrometry (LC-MS/MS).
The final method has been validated for urine according to EU regulations[1]
for determination of residues of veterinarian drugs in products of animal 
origin.
Cortisone and corticosteroids in the method
Experiments with clean up
Wash: Water. Elution: Methanol:
Initially, acceptable recoveries with negligible matrix interference for five 
synthetic corticosteroids (triamcinolone acetonid, flumethasone, 
dexamethasone, betamethasone and prednisolone) were produced from 
porcine urine (absolute recoveries: 74-125%) with a simple clean up 
procedure based on application of urine on a mixed mode polymeric strong 
anion exchange SPE column (Oasis MAX), washing with water and elution 
with methanol. From bovine urine, however, recoveries were low (10-27%).
Dilution experiments showed that the low recovery from bovine urine was 
caused by suppression of the signal during the measuring process and not 
due to losses during clean up.
Washing with acid or alkaline solutions in combination with elution with 
neutral methanol showed little effect towards reducing the suppression.
Wash: Neutral or acid water. Elution: Alkaline methanol:
By elution with alkaline methanol (0.1M ammonia in methanol), suppression 
was effectively eliminated for all analytes except prednisolone.
Wash: Alkaline water. Elution: Alkaline methanol:
By combining an alkaline washing procedure (0.1M ammonia in water) with 
elution with alkaline methanol (0.1M ammonia in methanol), suppression also 
decreased for prednisolone, and by reducing the amount of cleaned up 
sample injected to the chromatographic system from the equivalent of 
70 µl urine to approximately 20 µl, suppression of prednisolon was minimized
(absolute recoveries from porcine urine: 92-115%, from bovine urine: 99-
111%).
Final method
Hydrolysis:
To include conjugated corticosteroids in the analysis, the sample was 
hydrolysed with Helix Pomatia ß-glucuronidase/aryl sulfatase. This process 
showed some effects on the recoveries, so for the final method, which also 
included fluocinolone acetonid, 6α-methylprednisolone, beclomethasone and
prednisone, a quantification based on spiked samples put through the entire
analytical procedure was used. For quantification of triamcinolone acetonid an 
internal standard (triamcinolone acetonid-D6) was used.
Clean up:
3 ml of centrifuged urine was brought to pH 5.1 with acetate buffer,  
hydrolysed over night at 37°C with Helix Pomatia β-glucuronidase/aryl 
sulfatase and centrifuged. A SPE-column (Oasis MAX, 150 mg) was 
conditioned with methanol, water, and 1 ml 0.33M acetate buffer. 3 ml of the 
hydrolysed urine was loaded onto the column. After washing with water and 6 
ml 0.1M ammonia in water, corticosteroids were eluted with 2 ml 0.1M 
ammonia in methanol. After evaporation (40°C, nitrogen) and dissolution with 
300µl acetonitril and 900µl 0.1% formic acid, corticosteroids were quantified 
by LC/MS-MS.
LC/MS-MS:
LC-system: Agilent 1100; 10µl injected on a Zorbax Eclipse XDB (2.1x100 
mm, 1.7µm), 40°C; eluent: acetonitril/0.1% formic acid (3+7) at 0.22 ml/min.
MS: Waters Micromass Ultima (ESI-); two MS-MS daughter ions for each 
compound. 
Validation
During validation, the method showed average relative recoveries from 96 to 
103% with the exception of beclomethason (113%).
Average absolute recoveries were 81-99%.
Internal reproducibility, determined by triplicates from spiking at three different 
levels in six analytical series was 7-19% (at 2-4 µg/l) except for prednison and 
prednisolon (26-27% at 3-6 µg/l).
Quantification limits (decision limits[2], CCα at 1%) were demonstrated (by 
spiking 8-21 samples at CCα) to be not higher than 1 µg/l (3 µg/l for 
prednison and prednisolon). 
Detection capabilities[2] (CCβ at 5%) were demonstrated (by spiking 11-21 
samples at CCβ) to be not higher than 1,5 µg/l (4.5 µg/l for prednison and 
prednisolon).
[1] European Commission Decision 2002/657/EC, Off.J.Eur.Commun.L 221, (2002) 8.
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[2] Capability of detection – Part 1. ISO 11843-1:1997, Geneva 1997.
